A detailed history of Capstone Investment Advisors, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 10,406 shares of WVE stock, worth $71,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,406
Holding current value
$71,905
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.66 - $10.15 $69,303 - $105,620
10,406 New
10,406 $75,000
Q1 2024

May 01, 2024

BUY
$3.54 - $6.84 $15,930 - $30,780
4,500 Added 9.0%
54,500 $336,000
Q4 2023

Feb 12, 2024

BUY
$4.16 - $6.87 $208,000 - $343,500
50,000 New
50,000 $252,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $600M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.